Response Oncology (Response Oncology) Cash-to-Debt : No Debt ⁽¹⁾ (As of Mar. 2002)

Response Oncology Cash-to-Debt Chart

Response Oncology Annual Data
	Trend	Dec92	Dec93	Dec94	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01
Cash-to-Debt		Get a 7-Day Free Trial					0.06	0.03	0.18	0.21	No Debt

Response Oncology Quarterly Data
	Jun97	Sep97	Dec97	Mar98	Jun98	Sep98	Dec98	Mar99	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02
Cash-to-Debt	Get a 7-Day Free Trial															10.92	0.32	0.18	No Debt	No Debt

Competitive Comparison of Response Oncology's Cash-to-Debt

For the Medical Care Facilities subindustry, Response Oncology's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Oncology's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Response Oncology's Cash-to-Debt falls into.

Response Oncology Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Response Oncology's Cash to Debt Ratio for the fiscal year that ended in Dec. 2001 is calculated as:

Response Oncology had no debt ⁽¹⁾.

Response Oncology's Cash to Debt Ratio for the quarter that ended in Mar. 2002 is calculated as:

Response Oncology had no debt ⁽¹⁾.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Response Oncology  (GREY:ROIX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Response Oncology Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Response Oncology's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Oncology (Response Oncology) Business Description